Meanwhile, the negative correlation between PPARGC1A and activated mast cells suggests that it may attenuate the pro-inflammatory effects of mast cells in the tumor microenvironment by inhibiting their activation [43,44,45]. The gene discussed is PPARGC1A; the disease is neoplasm.